التفاصيل البيبلوغرافية
| العنوان: |
Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations. |
| المؤلفون: |
Dupré, T, Vuillaumier-Barrot, S, Chantret, I, Yayé, H S, Le Bizec, C, Afenjar, A, Altuzarra, C, Barnérias, C, Burglen, L, de Lonlay, P, Feillet, F, Napuri, S, Seta, N, Moore, S E H |
| المصدر: |
Journal of Medical Genetics; Nov2010, Vol. 47 Issue 11, p729-735, 7p, 2 Diagrams, 1 Chart, 2 Graphs |
| مستخلص: |
Background In type I congenital disorders of glycosylation (CDG I), proteins necessary for the biosynthesis of the lipid-linked oligosaccharide (LLO) required for protein N-glycosylation are defective. A deficiency in guanosine diphosphate-mannose: GlcNAc-PP-dolichol mannosyltransferase-1 (MT-1) causes CDG Ik (OMIM 608540), and only five patients, with severe multisystemic clinical presentations, have been described with this disease. Objective To characterise genetic, biochemical and clinical data in five new CDG Ik cases and compare these findings with those of the five previously described patients. Methods LLO biosynthesis was examined in skin biopsy fibroblasts, mannosyltransferases were assayed in microsomes prepared from these cells, and -encoding MT-1 was sequenced at the DNA and complementary DNA levels. Clinical data for the five new patients were collated. Results Cells from five patients with non-typed CDG I revealed accumulations of GlcNAc-PP-dolichol, the second intermediate in the biosynthesis of LLO. Assay of MT-1, -2 and -3, the first three mannosyltransferases required for extension of this intermediate, demonstrated only MT-1 to be deficient. DNA sequencing of revealed nine different mutations, seven of which have not been previously reported. Clinical presentations are severe, with dysmorphias, CNS involvement and ocular disturbances being prevalent. Conclusions 5 patients with CDG Ik are described, and their identification reveals that in France, this disease and CDG Ib (mannose phosphate isomerase deficiency: OMIM 602579) are the most frequently diagnosed CDG I after CDG Ia (phosphomannomutase 2 deficiency: OMIM 601785) and substantiate previous observations indicating that this disease presents at the severe end of the CDG I clinical spectrum. [ABSTRACT FROM PUBLISHER] |
|
Copyright of Journal of Medical Genetics is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
